| 2.35 0.11 (4.91%) | 06-16 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term | |
|||
| Targets | 6-month : | 2.74 | 1-year : | 3.2 |
| Resists | First : | 2.34 | Second : | 2.74 |
| Pivot price | 2.21 |
|||
| Supports | First : | 2.16 | Second : | 2.04 |
| MAs | MA(5) : | 2.25 |
MA(20) : | 2.2 |
| MA(100) : | 2.08  |
MA(250) : | 2.28 |
|
| MACD | MACD : | 0 |
Signal : | 0 |
| %K %D | K(14,3) : | 65.3 |
D(3) : | 63.2 |
| RSI | RSI(14): 63 |
|||
| 52-week | High : | 3.5 | Low : | 1.79 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ GEG ] has closed below upper band by 7.3%. Bollinger Bands are 17.1% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 2.31 - 2.33 | 2.33 - 2.34 |
| Low: | 2.22 - 2.23 | 2.23 - 2.25 |
| Close: | 2.28 - 2.3 | 2.3 - 2.32 |
Great Elm Group, Inc. operates primarily in two distinct sectors: durable medical equipment and investment management. Within its medical equipment division, the firm provides a range of respiratory support devices, including positive airway pressure (PAP) machines, ventilators, oxygen therapy units, and their necessary replacement parts. This segment also offers diagnostic sleep studies and leases out various medical apparatus. Complementing these activities, the company delivers financial investment portfolio management solutions. The enterprise, which was formerly known as Great Elm Capital Group, Inc., officially rebranded to its current name, Great Elm Group, Inc., in December 2020. Established in 1994, its main corporate office is situated in Waltham, Massachusetts.
Mon, 01 Jun 2026
Great Elm Group (GEG) insider Jason Reese gifts 99,637 shares to charity fund - Stock Titan
Thu, 07 May 2026
Great Elm Group Q3 2026 slides: revenue rises amid $9.8M unrealized losses - Investing.com
Thu, 07 May 2026
Earnings call transcript: Great Elm Group Q3 2026 shows revenue growth amid losses - Investing.com
Thu, 07 May 2026
Great Elm Group Q3 Earnings Call Highlights - Yahoo Finance
Wed, 06 May 2026
Great Elm Group Reports Fiscal 2026 Third Quarter Financial Results - GlobeNewswire
Tue, 05 May 2026
Great Elm Group, Inc. Schedules Fiscal 2026 Third Quarter Conference Call and Webcast - GlobeNewswire
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Distribution
|
|
| Shares Out | 31 (M) |
| Shares Float | 13 (M) |
| Held by Insiders | 32.3 (%) |
| Held by Institutions | 40.1 (%) |
| Shares Short | 190 (K) |
| Shares Short P.Month | 193 (K) |
| EPS | -0.81 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 1.33 |
| Profit Margin | -100.5 % |
| Operating Margin | -116.2 % |
| Return on Assets (ttm) | -6.8 % |
| Return on Equity (ttm) | -42.4 % |
| Qtrly Rev. Growth | 6.5 % |
| Gross Profit (p.s.) | -0.12 |
| Sales Per Share | 0.72 |
| EBITDA (p.s.) | -0.39 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 10 (M) |
| Levered Free Cash Flow | 8 (M) |
| PE Ratio | -2.88 |
| PEG Ratio | 0.7 |
| Price to Book value | 1.72 |
| Price to Sales | 3.16 |
| Price to Cash Flow | 7.27 |
| Dividend | 14.39 |
| Forward Dividend | 0 |
| Dividend Yield | 626% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|